ARTICLE | Company News
Merck neurology news
July 21, 2008 7:00 AM UTC
Merck will pay about $4.9 billion into its previously announced resolution program to settle state and federal claims in the U.S. related to pain drug Vioxx rofecoxib. About 97% of eligible claimants ...